Baldrick's?

Well, very well.

And it's interesting because just this morning I was listening in, lurking, if you will, to one of our scientific review meetings.

What we do is so we have worked with the scientific community, the community, the childhood cancer research community over now, 25 years.

And we've designed like a series of categories of grants, I guess we should call them.

that are intended for different purposes.

So there's infrastructure grants that allow an institution to build their team to get people on staff who can record all the data and all the things that are coming out of each patient's case and all the numbers from every test so that we can, and they go back then to a central place that then evaluates how that trial is performing.

their